SpringWorks Therapeutics (SWTX) Short Interest Ratio & Short Volume → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free SWTX Stock Alerts $41.46 -1.15 (-2.70%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SpringWorks Therapeutics Short Interest DataCurrent Short Interest10,690,000 sharesPrevious Short Interest10,010,000 sharesChange Vs. Previous Month+6.79%Dollar Volume Sold Short$483.19 millionShort Interest Ratio11.5 Days to CoverLast Record DateMay 15, 2024Outstanding Shares74,090,000 sharesPercentage of Shares Shorted14.43%Today's Trading Volume897,157 sharesAverage Trading Volume659,721 sharesToday's Volume Vs. Average136% Short Selling SpringWorks Therapeutics ? Sign up to receive the latest short interest report for SpringWorks Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSWTX Short Interest Over TimeSWTX Days to Cover Over TimeSWTX Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… SpringWorks Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202410,690,000 shares $483.19 million +6.8%N/A11.5 $45.20 4/30/202410,010,000 shares $467.37 million -5.0%N/A8.8 $46.69 4/15/202410,540,000 shares $448.06 million -1.1%N/A9.5 $42.51 3/31/202410,660,000 shares $524.69 million -4.6%N/A9.3 $49.22 3/15/202411,170,000 shares $561.63 million +0.4%N/A9.3 $50.28 2/29/202411,130,000 shares $548.26 million -2.5%N/A8.5 $49.26 Get the Latest News and Ratings for SWTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SpringWorks Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202411,410,000 shares $548.02 million +9.6%N/A7.6 $48.03 1/31/202410,410,000 shares $459.39 million No ChangeN/A7.7 $44.13 1/15/202410,410,000 shares $426.08 million -7.1%N/A8.3 $40.93 12/31/202311,210,000 shares $409.17 million +2.0%N/A9.2 $36.50 12/15/202310,990,000 shares $373.55 million +7.9%N/A9.8 $33.99 11/30/202310,190,000 shares $309.67 million +3.2%N/A10.2 $30.39 11/15/20239,870,000 shares $217.83 million -3.3%20.4%16.4 $22.07 10/31/202310,210,000 shares $233.81 million -1.7%21.2%17.7 $22.90 10/15/202310,390,000 shares $235.75 million -27.0%21.6%19.7 $22.69 9/30/202314,230,000 shares $329.00 million -2.4%29.5%27.6 $23.12 9/15/202314,580,000 shares $384.04 million +0.3%30.2%28.4 $26.34 8/31/202314,530,000 shares $409.46 million -3.7%N/A24.7 $28.18 8/15/202315,090,000 shares $439.72 million +0.1%N/A24 $29.14 7/31/202315,080,000 shares $473.21 million +1.0%N/A24 $31.38 7/15/202314,930,000 shares $427.00 million -0.1%31.5%23.1 $28.60 6/30/202314,940,000 shares $391.73 million +8.9%31.5%22.3 $26.22 6/15/202313,720,000 shares $384.98 million +11.0%28.9%19.8 $28.06 5/31/202312,360,000 shares $338.42 million +3.1%26.1%17.9 $27.38 5/15/202311,990,000 shares $368.45 million +3.7%25.3%17.1 $30.73 4/30/202311,560,000 shares $270.27 million +3.4%24.7%17.2 $23.38 4/15/202311,180,000 shares $267.54 million -4.1%23.9%16.3 $23.93 3/31/202311,660,000 shares $300.13 million -5.7%25.2%16.7 $25.74 3/15/202312,370,000 shares $391.02 million +6.5%26.8%16.8 $31.61 2/28/202311,620,000 shares $370.68 million +1.7%26.1%16.2 $31.90 2/15/202311,430,000 shares $348.27 million -6.7%25.7%16.5 $30.47 1/31/202312,250,000 shares $384.65 million -1.8%29.7%16.5 $31.40 1/15/202312,480,000 shares $362.04 million +9.1%28.0%16.5 $29.01 12/30/202211,440,000 shares $297.55 million +10.3%25.6%15.1 $26.01 12/15/202210,370,000 shares $234.05 million -10.7%23.5%13.8 $22.57 11/30/202211,610,000 shares $280.73 million -4.1%26.3%14.6 $24.18 11/15/202212,100,000 shares $331.54 million +9.5%27.4%14.5 $27.40 10/31/202211,050,000 shares $265.31 million +7.6%25.1%12 $24.01 10/15/202210,270,000 shares $258.80 million +4.4%23.3%11.4 $25.20 9/30/20229,840,000 shares $280.74 million +16.5%22.6%11 $28.53On June 10, Nvidia makes its next big move (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. 9/15/20228,450,000 shares $257.05 million -5.1%24.5%9 $30.42 8/31/20228,900,000 shares $247.15 million -4.2%23.3%8.9 $27.77 8/15/20229,290,000 shares $283.53 million -24.2%28.8%6.7 $30.52 7/31/202212,260,000 shares $366.33 million +3.3%38.8%9.4 $29.88 7/15/202211,870,000 shares $350.64 million +3.9%37.5%9.4 $29.54 6/30/202211,430,000 shares $281.41 million +7.3%36.1%9.2 $24.62 6/15/202210,650,000 shares $223.33 million +43.2%33.6%9 $20.97 5/31/20227,440,000 shares $140.91 million +21.8%23.5%7.5 $18.94 5/15/20226,110,000 shares $239.45 million +5.2%19.2%10.8 $39.19 4/30/20225,810,000 shares $249.31 million +17.6%18.3%13.1 $42.91 4/15/20224,940,000 shares $264.64 million +15.2%15.6%11.8 $53.57 3/31/20224,290,000 shares $242.13 million +10.6%13.6%9.7 $56.44 3/15/20223,880,000 shares $206.45 million +2.7%12.3%9.3 $53.21 2/28/20223,780,000 shares $213.91 million -1.6%11.9%9.1 $56.59 2/15/20223,840,000 shares $225.75 million +11.3%12.2%9.5 $58.79 1/31/20223,450,000 shares $192.10 million +23.7%11.8%8.7 $55.68 1/15/20222,790,000 shares $174.32 million +6.1%8.9%7.3 $62.48 12/31/20212,630,000 shares $163.01 million -9.0%8.3%7.9 $61.98 12/15/20212,890,000 shares $205.51 million -2.7%9.1%8.6 $71.11 11/30/20212,970,000 shares $213.39 million -12.7%9.4%9.1 $71.85 11/15/20213,400,000 shares $236.74 million -15.2%10.7%11.1 $69.63 10/29/20214,010,000 shares $268.91 million +7.8%12.7%13.2 $67.06 10/15/20213,720,000 shares $227.37 million +13.8%11.8%12.9 $61.12 9/30/20213,270,000 shares $207.45 million +4.5%10.4%12.3 $63.44 9/15/20213,130,000 shares $225.77 million -4.3%9.9%12.5 $72.13 8/31/20213,270,000 shares $245.58 million +3.8%10.4%13.8 $75.10 8/13/20213,150,000 shares $237.23 million -5.1%10.0%13.3 $75.31 7/30/20213,320,000 shares $284.52 million -1.8%10.9%14.7 $85.70 7/15/20213,380,000 shares $263.67 million -2.6%9.3%15 $78.01 6/30/20213,470,000 shares $285.96 million -1.4%9.5%15.1 $82.41 6/15/20213,520,000 shares $280.47 million -7.4%9.7%14.2 $79.68 5/28/20213,800,000 shares $309.85 million +0.3%10.4%13.8 $81.54 5/14/20213,790,000 shares $258.93 million -4.1%10.4%11.5 $68.32 4/30/20213,950,000 shares $289.46 million -3.0%10.9%11.4 $73.28 4/15/20214,070,000 shares $295.89 million +8.5%11.2%11.6 $72.70 3/31/20213,750,000 shares $256.80 million +9.7%10.6%9.9 $68.48 3/15/20213,420,000 shares $268.47 million +4.0%9.7%8.8 $78.50 2/26/20213,290,000 shares $292.81 million +8.2%9.7%9.5 $89.00 2/12/20213,040,000 shares $272.96 million -2.6%9.0%9.7 $89.79 1/29/20213,120,000 shares $251.41 million -10.3%9.3%9.2 $80.58 1/15/20213,480,000 shares $259.75 million -1.1%10.3%10.2 $74.64 12/31/20203,520,000 shares $255.13 million +18.9%10.4%10.6 $72.48 12/15/20202,960,000 shares $221.64 million -5.4%8.7%8.2 $74.88 11/30/20203,130,000 shares $212.84 million +2.6%9.2%8.5 $68.00 11/15/20203,050,000 shares $205.84 million +1.7%9.0%8.8 $67.49 10/30/20203,000,000 shares $178.44 million +6.4%9.0%9.2 $59.48 10/15/20202,820,000 shares $162.60 million -10.5%9.0%9.7 $57.66 9/30/20203,150,000 shares $150.16 million +37.0%10.1%11.4 $47.67 9/15/20202,300,000 shares $99.73 million +0.9%8.2%9.4 $43.36 8/31/20202,280,000 shares $101.25 million +5.1%8.1%10.7 $44.41“This will be one of the biggest revolutions ever.” - NVIDIA CEO (Ad)NVIDIA's CEO calls it the "next amazing revolution"... The Economist says its a "boon to humanity"... And Jeff Bezos is heavily invested in it.A new breakthrough tech could add up to $20 trillion to the U.S. economy. 8/14/20202,170,000 shares $89.06 million +3.3%7.7%10.3 $41.04 7/31/20202,100,000 shares $89.52 million +1.5%7.5%10.1 $42.63 7/15/20202,070,000 shares $77.07 million -2.8%7.4%10.2 $37.23 6/30/20202,130,000 shares $89.46 million +24.6%7.6%11.2 $42.00 6/15/20201,710,000 shares $73.46 million +3.6%6.1%11.1 $42.96 5/29/20201,650,000 shares $60.80 million -9.3%5.9%11 $36.85 5/15/20201,820,000 shares $68.09 million -4.2%6.5%11.8 $37.41 4/30/20201,900,000 shares $57.49 million -2.1%6.8%13.7 $30.26 4/15/20201,940,000 shares $52.17 million +13.5%6.9%15.7 $26.89 3/31/20201,710,000 shares $53.68 million +59.9%6.1%12.6 $31.39 3/13/20201,069,300 shares $31.81 million -7.8%3.8%5.2 $29.75 2/28/20201,160,000 shares $31.47 million No Change4.1%6.9 $27.13 2/14/20201,160,000 shares $38.57 million -4.1%4.1%7.2 $33.25 1/31/20201,210,000 shares $38.45 million -5.5%4.5%7.2 $31.78 1/15/20201,280,000 shares $38.98 million -0.8%4.8%7.5 $30.45 12/31/20191,290,000 shares $44.53 million No Change4.8%7.5 $34.52 SWTX Short Interest - Frequently Asked Questions What is SpringWorks Therapeutics' current short interest? Short interest is the volume of SpringWorks Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 10,690,000 shares of SWTX short. Learn More on SpringWorks Therapeutics' current short interest. What is a good short interest ratio for SpringWorks Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SWTX shares currently have a short interest ratio of 12.0. Learn More on SpringWorks Therapeutics's short interest ratio. Which institutional investors are shorting SpringWorks Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of SpringWorks Therapeutics: Walleye Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is SpringWorks Therapeutics' short interest increasing or decreasing? SpringWorks Therapeutics saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 10,690,000 shares, an increase of 6.8% from the previous total of 10,010,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does SpringWorks Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to SpringWorks Therapeutics: Allogene Therapeutics, Inc. (30.07%), Replimune Group, Inc. (19.17%), bluebird bio, Inc. (28.90%), AlloVir, Inc. (5.51%), Bio-Techne Co. (4.26%), Qiagen (1.39%), Repligen Co. (8.38%), Vaxcyte, Inc. (8.75%), Revolution Medicines, Inc. (7.84%), Exelixis, Inc. (3.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short SpringWorks Therapeutics stock? Short selling SWTX is an investing strategy that aims to generate trading profit from SpringWorks Therapeutics as its price is falling. SWTX shares are trading down $1.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against SpringWorks Therapeutics? A short squeeze for SpringWorks Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SWTX, which in turn drives the price of the stock up even further. How often is SpringWorks Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SWTX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Allogene Therapeutics Short Squeeze Replimune Group Short Squeeze bluebird bio Short Squeeze AlloVir Short Squeeze Bio-Techne Short Squeeze Qiagen Short Squeeze Repligen Short Squeeze Vaxcyte Short Squeeze Revolution Medicines Short Squeeze Exelixis Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SWTX) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SpringWorks Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.